Figure 5From: Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountModels for tumour growth curves. After multiple administration of (A)90Y, (B)111In, (C)177Lu or (D)213Bi to a 300-mg tumour for different tumour doubling times. The same amount of peptide was used as indicated in Figure 4.Back to article page